Pharmasset's P2P Acquisition

Pharmasset raised a round of funding on January 19, 2012. Investors include Gilead Sciences.

Pharmasset is a clinical-stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to treat viral infections. Pharmasset's primary focus is the development of o…

Articles about Pharmasset's P2P Acquisition: